Caseware UK (AP4) 2024.0.164 2024.0.164 2024-12-312024-12-31falsefalse2024-01-01No description of principal activity68falsetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 12345643 2024-01-01 2024-12-31 12345643 2023-01-01 2023-12-31 12345643 2024-12-31 12345643 2023-12-31 12345643 2023-01-01 12345643 1 2024-01-01 2024-12-31 12345643 d:Director2 2024-01-01 2024-12-31 12345643 c:ComputerEquipment 2024-01-01 2024-12-31 12345643 c:ComputerEquipment 2024-12-31 12345643 c:ComputerEquipment 2023-12-31 12345643 c:ComputerEquipment c:OwnedOrFreeholdAssets 2024-01-01 2024-12-31 12345643 c:CurrentFinancialInstruments 2024-12-31 12345643 c:CurrentFinancialInstruments 2023-12-31 12345643 c:CurrentFinancialInstruments c:WithinOneYear 2024-12-31 12345643 c:CurrentFinancialInstruments c:WithinOneYear 2023-12-31 12345643 c:ShareCapital 2024-01-01 2024-12-31 12345643 c:ShareCapital 2024-12-31 12345643 c:ShareCapital 2023-01-01 2023-12-31 12345643 c:ShareCapital 2023-12-31 12345643 c:ShareCapital 2023-01-01 12345643 c:SharePremium 2024-01-01 2024-12-31 12345643 c:SharePremium 2024-12-31 12345643 c:SharePremium 2023-01-01 2023-12-31 12345643 c:SharePremium 2023-12-31 12345643 c:SharePremium 2023-01-01 12345643 c:RetainedEarningsAccumulatedLosses 2024-01-01 2024-12-31 12345643 c:RetainedEarningsAccumulatedLosses 2024-12-31 12345643 c:RetainedEarningsAccumulatedLosses 2023-01-01 2023-12-31 12345643 c:RetainedEarningsAccumulatedLosses 2023-12-31 12345643 c:RetainedEarningsAccumulatedLosses 2023-01-01 12345643 d:OrdinaryShareClass1 2024-01-01 2024-12-31 12345643 d:OrdinaryShareClass1 2024-12-31 12345643 d:OrdinaryShareClass1 2023-12-31 12345643 d:FRS102 2024-01-01 2024-12-31 12345643 d:AuditExempt-NoAccountantsReport 2024-01-01 2024-12-31 12345643 d:FullAccounts 2024-01-01 2024-12-31 12345643 d:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 12345643 2 2024-01-01 2024-12-31 12345643 6 2024-01-01 2024-12-31 12345643 e:PoundSterling 2024-01-01 2024-12-31 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 12345643










FIRST LONGEVITY LTD








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 DECEMBER 2024

 
FIRST LONGEVITY LTD
REGISTERED NUMBER: 12345643

BALANCE SHEET
AS AT 31 DECEMBER 2024

2024
2023
Note
£
£

Fixed assets
  

Tangible assets
 4 
1,911
2,977

Investments
 5 
-
32,775

  
1,911
35,752

Current assets
  

Debtors: amounts falling due within one year
 6 
50,789
30,916

Cash at bank and in hand
 7 
131,707
121,116

  
182,496
152,032

Current Liabilities
  

Creditors: amounts falling due within one year
 8 
(145,307)
(108,603)

Net current assets
  
 
 
37,189
 
 
43,429

Total assets less current liabilities
  
39,100
79,181

  

Net assets
  
39,100
79,181


Capital and reserves
  

Called up share capital 
 9 
1,572
1,476

Share premium account
  
1,231,843
955,931

Profit and loss account
  
(1,194,315)
(878,226)

  
39,100
79,181


Page 1

 
FIRST LONGEVITY LTD
REGISTERED NUMBER: 12345643

BALANCE SHEET (CONTINUED)
AS AT 31 DECEMBER 2024

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




P J Newman
Director

Date: 10 September 2025

The notes on pages 4 to 9 form part of these financial statements.

Page 2

 
FIRST LONGEVITY LTD
 

STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2024


Called up share capital
Share premium account
Profit and loss account
Total equity

£
£
£
£


At 1 January 2023
1,384
678,827
(526,341)
153,870



Loss for the year
-
-
(351,885)
(351,885)

Shares issued during the year
92
277,104
-
277,196



At 1 January 2024
1,476
955,931
(878,226)
79,181



Loss for the year
-
-
(316,089)
(316,089)

Shares issued during the year
96
275,912
-
276,008


At 31 December 2024
1,572
1,231,843
(1,194,315)
39,100


The notes on pages 4 to 9 form part of these financial statements.

Page 3

 
FIRST LONGEVITY LTD
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

1.


General information

First Longevity Ltd is a private company limited by shares and incorporated in England & Wales. The address of its registered office is 2 Communications Road, Greenham Business Park, Newbury, Berkshire, RG19 6AB.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Going concern

At the time of approving the financial statements,  the directors have a reasonable expectation that the Company has adequate resources and that its investors and creditors will continue to support it to continue in operational existence for the foreseeable future. Thus, the directors believe that the financial statements have been prepared appropriately on a going concern basis.  

 
2.3

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.4

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.5

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Page 4

 
FIRST LONGEVITY LTD
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)


2.5
Tangible fixed assets (continued)

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Computer equipment
-
33%

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.6

Valuation of investments

Investments in subsidiaries are measured at cost less accumulated impairment.

Investments in unlisted Company shares, whose market value can be reliably determined, are remeasured to market value at each balance sheet date. Gains and losses on remeasurement are recognised in the Statement of Comprehensive Income for the period. Where market value cannot be reliably determined, such investments are stated at historic cost less impairment.

Investments in listed company shares are remeasured to market value at each balance sheet date. Gains and losses on remeasurement are recognised in profit or loss for the period.

 
2.7

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.8

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.9

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Page 5

 
FIRST LONGEVITY LTD
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

 
2.10

Financial instruments

The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the Company's Balance Sheet when the Company becomes party to the contractual provisions of the instrument.

Basic financial assets

Basic financial assets, which include trade and other debtors, cash and bank balances, are initially measured at their transaction price (adjusted for transaction costs except in the initial measurement of financial assets that are subsequently measured at fair value through profit and loss) and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other debtors due with the operating cycle fall into this category of financial instruments.


3.


Employees

The average monthly number of employees, including the directors, during the year was as follows:


        2024
        2023
            No.
            No.







Employee
6
8

Page 6

 
FIRST LONGEVITY LTD
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

4.


Tangible fixed assets





Computer equipment

£



Cost or valuation


At 1 January 2024
10,004


Additions
646



At 31 December 2024

10,650



Depreciation


At 1 January 2024
7,027


Charge for the year on owned assets
1,712



At 31 December 2024

8,739



Net book value



At 31 December 2024
1,911



At 31 December 2023
2,977


5.


Fixed asset investments





Listed investments

£





At 1 January 2024
32,775


Disposals
(32,775)



At 31 December 2024
-




Page 7

 
FIRST LONGEVITY LTD
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

6.


Debtors

2024
2023
£
£


Trade debtors
30,833
5,988

Other debtors
13,002
10,430

Prepayments and accrued income
6,954
14,498

50,789
30,916



7.


Cash and cash equivalents

2024
2023
£
£

Cash at bank and in hand
131,707
121,116



8.


Creditors: Amounts falling due within one year

2024
2023
£
£

Trade creditors
69,842
81,917

Other taxation and social security
36,897
16,633

Other creditors
17,000
881

Accruals and deferred income
21,568
9,172

145,307
108,603



9.


Share capital

2024
2023
£
£
Allotted, called up and fully paid



1,571,703 (2023 - 1,475,867) Ordinary share of £0.001 each
1,572
1,476


During the year, 95,386 Ordinary shares of £0.001 each were issued and paid for the consideration of £276,008. 


10.


Pension commitments

The Company operates a defined contributions pension scheme. The assets of the scheme are held separately from those of the Company  in an independently administered fund. The pension cost charge represents contributions payable by the Company to the fund and amounted to £3,853 (2023 - £5,034) . Contributions totalling £757 (2023 - £881) were payable to the fund at the balance sheet date and are included in creditors.

Page 8

 
FIRST LONGEVITY LTD
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

11.


Post balance sheet events

Following the year end, the Company raised £330,000 by way of a share issue. This resulted in an increase in cash and capital and reserves of £330,000.  


12.


Controlling party

The Company is controlled by its directors


Page 9